Dicot Pharma AB (STO:DICOT)
Sweden · Delayed Price · Currency is SEK 0.5340
+0.0070 (1.33%)
At close: Oct 31, 2025
Dicot Pharma AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
1.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AB Volvo | 493.79B |
| Telefonaktiebolaget LM Ericsson | 240.31B |
| H & M Hennes & Mauritz AB | 231.26B |
| Atlas Copco AB | 171.55B |
| ASSA ABLOY AB | 153.68B |
| Investor AB | 133.31B |
| Sandvik AB | 120.37B |
| Skandinaviska Enskilda Banken AB | 76.49B |